Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

21 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Specific anticancer treatments in the last 3 months of life: a French experience.
Viel E, Chaigneau L, Fanton E, Kalbacher E, Thiery-Vuillemnin A, Villanueva C, Dobi E, Curtit E, Almotlak H, Aubry R, Pivot X. Viel E, et al. Among authors: almotlak h. Support Care Cancer. 2013 Feb;21(2):405-12. doi: 10.1007/s00520-012-1529-1. Epub 2012 Jun 27. Support Care Cancer. 2013. PMID: 22736464
Impact of everolimus blood concentration on its anti-cancer activity in patients with metastatic renal cell carcinoma.
Thiery-Vuillemin A, Mouillet G, Nguyen Tan Hon T, Montcuquet P, Maurina T, Almotlak H, Stein U, Montange D, Foubert A, Nerich V, Pivot X, Royer B. Thiery-Vuillemin A, et al. Among authors: almotlak h. Cancer Chemother Pharmacol. 2014 May;73(5):999-1007. doi: 10.1007/s00280-014-2435-7. Epub 2014 Mar 30. Cancer Chemother Pharmacol. 2014. PMID: 24682543
[Prevalence and management of pain in patients with metastatic cancer in Franche-Comté].
Dénommé F, Kroemer M, Montcuquet P, Nallet G, Thiery-Vuillemin A, Bazan F, Mouillet G, Villanueva C, Demarchi M, Stein U, Almotlak H, Chaigneau L, Curtit E, Meneveau N, Maurina T, Dobi E, Hon TN, Cals L, Mansi L, Verlut C, Pana-Katatali H, Caubet M, Paillard MJ, Limat S, Pivot X, Nerich V. Dénommé F, et al. Among authors: almotlak h. Bull Cancer. 2016 Oct;103(10):849-860. doi: 10.1016/j.bulcan.2016.08.007. Epub 2016 Sep 29. Bull Cancer. 2016. PMID: 27692731 French.
Feasibility of health-related quality of life (HRQoL) assessment for cancer patients using electronic patient-reported outcome (ePRO) in daily clinical practice.
Mouillet G, Falcoz A, Fritzsch J, Almotlak H, Jacoulet P, Pivot X, Villanueva C, Mansi L, Kim S, Curtit E, Meneveau N, Adotevi O, Jary M, Eberst G, Vienot A, Calcagno F, Pozet A, Djoumakh O, Borg C, Westeel V, Anota A, Paget-Bailly S. Mouillet G, et al. Among authors: almotlak h. Qual Life Res. 2021 Nov;30(11):3255-3266. doi: 10.1007/s11136-020-02721-0. Epub 2021 Jan 2. Qual Life Res. 2021. PMID: 33387291
[Systemic treatment of locally advanced or metastatic penile cancer].
Gassian N, Frontczak A, El Kaddissi A, Calcagno F, Almotlak H, Barkatz J, Mouillet G, Maurina T, Stein U, Nguyen Tan Hon T, Murez T, Thiery-Vuillemin A. Gassian N, et al. Among authors: almotlak h. Bull Cancer. 2020 Jun;107(5S):S17-S23. doi: 10.1016/S0007-4551(20)30274-5. Bull Cancer. 2020. PMID: 32620202 Review. French.
Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19).
Lièvre A, Turpin A, Ray-Coquard I, Le Malicot K, Thariat J, Ahle G, Neuzillet C, Paoletti X, Bouché O, Aldabbagh K, Michel P, Debieuvre D, Canellas A, Wislez M, Laurent L, Mabro M, Colle R, Hardy-Bessard AC, Mansi L, Colomba E, Bourhis J, Gorphe P, Pointreau Y, Idbaih A, Ursu R, Di Stefano AL, Zalcman G, Aparicio T; GCO-002 CACOVID-19 collaborators/investigators. Lièvre A, et al. Eur J Cancer. 2020 Dec;141:62-81. doi: 10.1016/j.ejca.2020.09.035. Epub 2020 Oct 8. Eur J Cancer. 2020. PMID: 33129039 Free PMC article.
Prognostic value of CD4+ T lymphopenia in non-small cell lung Cancer.
Eberst G, Vernerey D, Laheurte C, Meurisse A, Kaulek V, Cuche L, Jacoulet P, Almotlak H, Lahourcade J, Gainet-Brun M, Fabre E, Le Pimpec-Barthes F, Adotevi O, Westeel V. Eberst G, et al. Among authors: almotlak h. BMC Cancer. 2022 May 11;22(1):529. doi: 10.1186/s12885-022-09628-8. BMC Cancer. 2022. PMID: 35546670 Free PMC article.
Open-label, randomized multicentre phase II study to assess the efficacy and tolerability of sunitinib by dose administration regimen (dose modification or dose interruptions) in patients with advanced or metastatic renal cell carcinoma: study protocol of the SURF trial.
Mouillet G, Paillard MJ, Maurina T, Vernerey D, Nguyen Tan Hon T, Almotlak H, Stein U, Calcagno F, Berthod D, Robert E, Meurisse A, Thiery-Vuillemin A. Mouillet G, et al. Among authors: almotlak h. Trials. 2018 Apr 12;19(1):221. doi: 10.1186/s13063-018-2613-8. Trials. 2018. PMID: 29650037 Free PMC article.
21 results